- Home
- WENN vs OPRX Comparison
WENN vs OPRX Comparison
Compare WENN & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WENN
- OPRX
- Stock Information
- Founded
- WENN 2025
- OPRX 2006
- Country
- WENN United States
- OPRX United States
- Employees
- WENN N/A
- OPRX N/A
- Industry
- WENN
- OPRX Business Services
- Sector
- WENN
- OPRX Consumer Discretionary
- Exchange
- WENN Nasdaq
- OPRX Nasdaq
- Market Cap
- WENN 387.6M
- OPRX 380.6M
- IPO Year
- WENN 2025
- OPRX N/A
- Fundamental
- Price
- WENN $10.16
- OPRX $14.63
- Analyst Decision
- WENN
- OPRX Buy
- Analyst Count
- WENN 0
- OPRX 6
- Target Price
- WENN N/A
- OPRX $14.83
- AVG Volume (30 Days)
- WENN 70.1K
- OPRX 332.7K
- Earning Date
- WENN 01-01-0001
- OPRX 11-06-2025
- Dividend Yield
- WENN N/A
- OPRX N/A
- EPS Growth
- WENN N/A
- OPRX N/A
- EPS
- WENN N/A
- OPRX 0.00
- Revenue
- WENN N/A
- OPRX $109,506,000.00
- Revenue This Year
- WENN N/A
- OPRX $17.92
- Revenue Next Year
- WENN N/A
- OPRX $10.91
- P/E Ratio
- WENN N/A
- OPRX $7,970.62
- Revenue Growth
- WENN N/A
- OPRX 24.18
- 52 Week Low
- WENN $9.67
- OPRX $3.99
- 52 Week High
- WENN $10.40
- OPRX $22.25
- Technical
- Relative Strength Index (RSI)
- WENN N/A
- OPRX 38.01
- Support Level
- WENN N/A
- OPRX $13.57
- Resistance Level
- WENN N/A
- OPRX $16.37
- Average True Range (ATR)
- WENN 0.00
- OPRX 1.11
- MACD
- WENN 0.00
- OPRX -0.36
- Stochastic Oscillator
- WENN 0.00
- OPRX 18.22
About WENN Wen Acquisition Corp Class A Ordinary Shares
Wen Acquisition Corp is a blank check company.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.